Institute for Protein Design

The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

Amazon Science is a research and development organization within Amazon that focuses on developing new technologies and products in the fields of artificial intelligence, machine learning, and computer science. The organization is home to a team of world-renowned scientists and engineers who are working on a wide range of projects, including developing new algorithms for machine learning, building new computer vision systems, and creating new natural language processing tools. Amazon Science is also responsible for developing new products and services that use these technologies, such as the Amazon Echo and the Amazon Fire TV.

Google Research is a team of scientists and engineers working on a wide range of topics in computer science, including artificial intelligence, machine learning, and quantum computing. Our mission is to advance the state of the art in these fields and to develop new technologies that can benefit society. We publish hundreds of research papers each year and collaborate with researchers from around the world. Our work has led to the development of many new products and services, including Google Search, Google Translate, and Google Maps.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

GenInnov is a generative innovation fund that provides a platform for investors seeking to be at the forefront of technological advancement. The fund invests in companies driving transformative change across multiple sectors and geographies, prioritizing material innovations with demonstrable profitability and global reach. GenInnov operates with a research-driven approach, focusing on investing in material innovations that are monetizable, profitable, and transformative, rather than incremental. The fund looks at various domains such as technology, robotics, consumer electronics, biotech, healthcare, mobility, and clean tech, aiming to amplify human creativity through machine intelligence.

Variational AI is a company that uses generative AI to discover novel drug-like small molecules with optimized properties for defined targets. Their platform, Enki™, is the first commercially accessible foundation model for small molecules. It is designed to make generating novel molecule structures easy, with no data required. Users simply define their target product profile (TPP) and Enki does the rest. Enki is an ensemble of generative algorithms trained on decades worth of experimental data with proven results. The company was founded in September 2019 and is based in Vancouver, BC, Canada.

Valo is a company that uses AI-driven technology to transform the discovery and development of life-changing medicines. They combine machine learning, tissue biology, and patient data to create a suite of powerful capabilities that bring the future of drug discovery and development to bear. Valo's team of software engineers, data scientists, biologists, medicinal chemists, and big-picture thinkers are dedicated to advancing the combined power of technology and patient data.

Fathom5 is a company that specializes in the intersection of AI and industrial systems. They offer a range of products and services to help customers build the industrial systems of the future. Their solutions are focused on critical infrastructure, making it more resilient, flexible, and efficient.

TensorFlow is an end-to-end platform for machine learning. It provides a wide range of tools and resources to help developers build, train, and deploy ML models. TensorFlow is used by researchers and developers all over the world to solve real-world problems in a variety of domains, including computer vision, natural language processing, and robotics.

Figure is a pioneering AI robotics company that is revolutionizing the industry by introducing a general-purpose humanoid robot to the global workforce. By combining cutting-edge AI technology with the dexterity of the human form, Figure aims to enhance human capabilities, address labor shortages, and improve workplace safety. The company's innovative approach is set to transform various sectors such as manufacturing, logistics, warehousing, and retail. With a team of experts boasting over 100 years of combined experience in AI and humanoid robotics, Figure is at the forefront of shaping the future of work.

PyTorch is an open-source machine learning library based on the Torch library. It is used for applications such as computer vision, natural language processing, and reinforcement learning. PyTorch is known for its flexibility and ease of use, making it a popular choice for researchers and developers in the field of artificial intelligence.

OpenAI01.net is an AI tool that offers free usage with some limitations. It provides a new series of AI models designed to spend more time thinking before responding, capable of reasoning through complex tasks and solving harder problems in science, coding, and math. Users can ask questions and get answers for free, with the option to select different models based on credits. The tool excels in complex reasoning tasks and has shown impressive performance in various benchmarks.

Carnegie Mellon University's School of Computer Science (SCS) is a world-renowned institution dedicated to advancing the field of computer science and training the next generation of innovators. With a rich history of groundbreaking research and a commitment to excellence in education, SCS offers a comprehensive range of programs, from undergraduate to doctoral levels, covering various specializations within computer science. The school's faculty are leading experts in their respective fields, actively engaged in cutting-edge research and collaborating with industry partners to solve real-world problems. SCS graduates are highly sought after by top companies and organizations worldwide, recognized for their exceptional skills and ability to drive innovation.

Experiments with Google is a website that showcases a collection of experiments created by coders using Chrome, Android, AI, AR, and more. The experiments are designed to inspire others to create new experiments and explore the possibilities of these technologies. The website also provides helpful tools and resources for creating experiments.

Blue River Technology is a company that creates intelligent machinery for agriculture. They use computer vision, machine learning, and robotics to create solutions that help farmers improve yields and minimize their environmental impact. The company is committed to creating a people-first culture where everyone has a common mission: to solve monumental challenges in agriculture.

The AI in Finance Summit is a leading conference that brings together experts in artificial intelligence and finance to discuss the latest trends and developments in the field. The summit features a variety of speakers, including researchers, practitioners, and investors, who share their insights on how AI is being used to transform the financial industry. The summit also provides a platform for attendees to network and learn from each other.

The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

Atomwise is an artificial intelligence (AI)-driven drug discovery company that uses machine learning to discover and develop new small molecule medicines. The company's AI engine combines the power of convolutional neural networks with massive chemical libraries to identify new drug candidates. Atomwise has a wholly owned pipeline of drug discovery programs and also partners with other pharmaceutical companies to co-develop drugs. The company's investors include prominent venture capital firms and pharmaceutical companies.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

System Pro is a cutting-edge platform that revolutionizes the way users search, synthesize, and contextualize scientific research, with a primary focus on health and life sciences. It offers a fast and reliable solution for accessing valuable information in the field of research, empowering users to stay informed and make informed decisions. By leveraging advanced technology, System Pro enhances the research experience by providing a seamless and efficient search process, enabling users to discover relevant content effortlessly.

Synthace is a software and expertise platform designed for Discovery Biology Teams to streamline and optimize their experiments in assay development, media optimization, and purification process development. The platform offers software solutions, training, and on-site support from specialists to help scientists conduct experiments more efficiently and effectively. By leveraging multifactorial methods and automation, Synthace aims to accelerate drug discovery processes and deliver faster, definitive results.

Valo is a company that uses AI-driven technology to transform the discovery and development of life-changing medicines. They combine machine learning, tissue biology, and patient data to create a suite of powerful capabilities that bring the future of drug discovery and development to bear. Valo's team of software engineers, data scientists, biologists, medicinal chemists, and big-picture thinkers are dedicated to advancing the combined power of technology and patient data.

Atomwise is an artificial intelligence (AI)-driven drug discovery company that uses machine learning to discover and develop new small molecule medicines. The company's AI engine combines the power of convolutional neural networks with massive chemical libraries to identify new drug candidates. Atomwise has a wholly owned pipeline of drug discovery programs and also partners with other pharmaceutical companies to co-develop drugs. The company's investors include prominent venture capital firms and pharmaceutical companies.

Deepcell is a company that develops technology for single-cell analysis. Their REM-I platform combines label-free imaging, deep learning, and gentle sorting to leverage single cell morphology as a high-dimensional quantitative readout. This allows researchers to gain insights into cells' phenotype and function to address important research questions across biology.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

Allchemy is a resource-aware AI platform for drug discovery. It combines state-of-the-art computational synthesis with AI algorithms to predict molecular properties. Within minutes, Allchemy creates thousands of synthesizable lead candidates meeting user-defined profiles of drug-likeness, affinity towards specific proteins, toxicity, and a range of other physical-chemical measures. Allchemy encompasses the entire resource-to-drug design process and has been used in academic, corporate and classified environments worldwide to: Design synthesizable leads targeting specific proteins Evolve scaffolds similar to desired drugs Design “circular” drug syntheses from renewable materials Interface with and instruct automated synthesis platforms and optimize pilot-scale processes Operate “iterative synthesis” schemes Predict side reactions and create forensic “synthetic signatures” of hazardous/toxic molecules Design synthetic degradation and recovery cycles for various types of feedstocks and functional target molecules

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

Wildlife Insights is an AI application that brings cutting-edge technology to wildlife conservation. It streamlines decision-making by providing machine learning models and tools to manage, analyze, and share camera trap data. Users can easily upload, identify, analyze, and discover wildlife through the platform, enabling better decisions to help wildlife thrive globally.

BioloGPT is an AI tool designed to answer biology-related questions with insights and graphs. It provides information on various topics such as maintaining a healthy gut microbiome, foods for a healthy immune system, effects of cannabis on the brain, risks of Covid-19 vaccines, and advancements in psoriasis treatment. The tool is updated daily and cites full papers to support its answers.

Bichos ID de Fucesa is an AI tool that allows users to explore and identify insects, arachnids, and other arthropods using artificial intelligence. Users can discover the most searched bugs, explore new discoveries made by the community, and view curated organisms. The platform aims to expand knowledge about the fascinating world of arthropods through AI-powered identification.

HoloEye.AI is a transformative AI biological intelligence company that leverages cutting-edge artificial intelligence technology to revolutionize the field of biological research. The platform offers advanced AI solutions for analyzing complex biological data, enabling researchers to gain deeper insights and accelerate scientific discoveries.

CellProfiler is an AI tool designed for biologists to analyze and process images automatically. It allows users to load image-processing modules, adjust settings, measure phenotypes, export data, and classify phenotypes using machine learning. The application is user-friendly and provides a seamless experience for biologists to analyze complex or subtle phenotypes in their images.

Salt AI is a development engine tailored for life sciences organizations, aiming to accelerate advancements in the field by enabling faster adoption and utilization of AI technologies. The platform offers reliable and reproducible AI processes, optimized for speed and efficiency, and promotes transparency and collaboration within workflows. With a focus on supporting best-in-class life sciences research models, Salt AI empowers users to enhance their understanding of biological processes through flexible and performant AI solutions.

Lavo Life Sciences is an AI-accelerated crystal structure prediction application that aims to accelerate drug development by providing accurate crystal structure predictions for small molecule drugs. The application helps in de-risking pipelines, optimizing solid-state formulations, and avoiding late-stage surprises through cutting-edge AI technology. Lavo Life Sciences combines expertise in AI and computational chemistry to offer fast and efficient solutions for drug development teams, enabling them to discover novel polymorphs and make informed decisions to enhance drug development processes.

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

C&EN, a publication of the American Chemical Society, provides the latest news and insights on the chemical industry, including research, technology, business, and policy. It covers a wide range of topics, including analytical chemistry, biological chemistry, business, careers, education, energy, environment, food, materials, people, pharmaceuticals, physical chemistry, policy, research integrity, safety, and synthesis.

Chemprop is a PyTorch-based framework for training and evaluating message-passing neural networks (MPNNs) for molecular property prediction. Originally developed for research purposes, Chemprop offers a comprehensive set of tools and features for training models and analyzing molecular representations. The package underwent a recent major release (v2.0.0) with significant improvements and updates.

Cambrian Copilot is an AI tool designed for researchers and engineers to stay up-to-date with the latest machine learning research. It provides a platform to search over 240,000 ML papers, understand complex details, and automate literature reviews, making the process more efficient and accessible.

Mnemonic AI is an advanced Customer Intelligence AI tool that specializes in creating AI Personas and Digital Twin of the Customer. It helps organizations of all sizes better understand individuals by developing artificial intelligence solutions to tailor messages to their state of mind. The tool offers features such as Buyer Persona Creation, Digital Twin of the Customer, Case Studies, Whitepaper, OCEAN Personality Analysis, Schwartz Universal Values, and easy data source integrations.

functime is a time-series machine learning tool designed for scalable analysis. It offers a comprehensive set of functions for forecasting, evaluation, and analysis of time-series data. With features like scoring, ranking, and plotting functions, functime simplifies the process of evaluating thousands of forecasts simultaneously. It serves as an AI copilot to help analysts analyze and compare trends, seasonality, and causal factors in forecasts. The tool also provides detailed API reference for seamless integration into existing workflows.

Kolank is an AI tool that offers a unified API for various AI models, including Generative AI. It provides features such as load balancing, fallbacks, cost and performance metrics. Users can easily access and utilize AI models for tasks like text generation, image analysis, and video processing. Kolank simplifies the integration of AI capabilities into applications, making it a valuable resource for developers and businesses seeking to leverage AI technology.

Promptmakr is an AI-powered platform that serves as a marketplace for buying and selling AI prompts. It provides a convenient space for users to access a variety of prompts for their AI projects. With a user-friendly interface, Promptmakr aims to streamline the process of acquiring prompts and enhancing the efficiency of AI development. Whether you are a developer looking for inspiration or a business seeking tailored prompts, Promptmakr offers a diverse range of options to meet your needs.